Aptiv Solutions, the U.S.-based provider of biopharmaceutical and medical device development services has set up an Adaptive Clinical Trials Innovation Center, according to Pharma Times.

The Innovation Center will work to improve drug development processes through the use of adaptive designs, Aptiv said. According to Reinhard Eisebitt, executive vice president and head of the Innovation Center, Aptiv Solutions is “the only company to combine clinical execution capabilities, statistical and scientific expertise, and a suite of integrated technology to provide clients with a full-service adaptive clinical trial offering.”

Adaptive Clinical Trials Innovation Center will also provide consulting services to pharmaceutical and biotechnology companies, as well as regulatory authorities, on best practices in the field, including assistance with trial design, simulation and execution, development of software tools for adaptive trials, and will work with project teams in clinical operations and data management as well as statistics groups during study conduct.